Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
France: Echosens appoints Romain Baujard as group CEO
Echosens, a France-based specialist diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases, has appointed Romain Baujard as group […]
Echosens, a France-based specialist diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases, has appointed Romain Baujard as group […]
France: Echosens appoints Romain Baujard as group CEO
April 28, 2026
Diagnostics
Healthcare
News
People
Astorg
Namibia: Salt Capital and Proparco acquire The Namibian Oncology Centre
Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have acquired The Namibian Oncology Centre (NOC), […]
Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have acquired The Namibian Oncology Centre (NOC), […]
Namibia: Salt Capital and Proparco acquire The Namibian Oncology Centre
April 28, 2026
Buy Out
Healthcare
Hospitals and Clinics
M&A
M&A Deals
UK: Allica Bank expands lending and products in support of healthcare businesses
UK-based business challenger bank, Allica Bank, is announced it is expanding its lending and product flexibility in support of UK healthcare operators. The changes enable the bank to better support […]
UK-based business challenger bank, Allica Bank, is announced it is expanding its lending and product flexibility in support of UK healthcare operators. The changes enable the bank to better support […]
UK: Allica Bank expands lending and products in support of healthcare businesses
April 28, 2026
Debt
Healthcare
News
Allica Bank
Anthony Newman
Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn
Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn, consisting of cash and a US$50m […]
Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn, consisting of cash and a US$50m […]
Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn
April 27, 2026
Buy Out
Life Sciences
M&A
Medtech – Diagnostics
News
France: Servier acquires Day One Bio for US$2.5bn
France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted therapies for people of all ages […]
France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted therapies for people of all ages […]
France: Servier acquires Day One Bio for US$2.5bn
April 27, 2026
M&A
Manufacturing – Specialty Pharma
News
Pharma
Day One Bio
Netherlands: Waterland raises €4.6bn in less than four months
Netherlands-based independent PE investment group, Waterland, has announced the closing of its 10th institutional flagship fund Waterland Private Equity Fund X (WPEF X) at €4bn (US$4.7bn), alongside Waterland Partnership Fund II […]
Netherlands-based independent PE investment group, Waterland, has announced the closing of its 10th institutional flagship fund Waterland Private Equity Fund X (WPEF X) at €4bn (US$4.7bn), alongside Waterland Partnership Fund II […]
Netherlands: Waterland raises €4.6bn in less than four months
April 27, 2026
Buy Out
Healthcare
News
Cedric Van Cauwenberghe
Evercore
Hungary: LDC-backed Panthera Biopartners takes first major step in European expansion strategy
Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a Hungary-based independent clinical research site network. […]
Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a Hungary-based independent clinical research site network. […]
Hungary: LDC-backed Panthera Biopartners takes first major step in European expansion strategy
April 27, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: Partners Group closes latest private equity secondaries programme with over US$9bn of total commitments
Partners Group, one of the largest firms in the global private markets industry, has closed its eighth private equity secondaries programme with over US$9bn in total client commitments. The programme […]
Partners Group, one of the largest firms in the global private markets industry, has closed its eighth private equity secondaries programme with over US$9bn in total client commitments. The programme […]
Switzerland: Partners Group closes latest private equity secondaries programme with over US$9bn of total commitments
April 24, 2026
Buy Out
News
Anthony Shontz
Partners Group
Switzerland
Netherlands: Alcami to acquire contract packaging organisation Tjoapack
Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners acquired a majority stake in Tjoapack […]
Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners acquired a majority stake in Tjoapack […]
Netherlands: Alcami to acquire contract packaging organisation Tjoapack
April 24, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
France: Kurma Partners closes Biofund IV at €215m
Kurma Partners, a European healthcare venture capital firm and a Eurazeo group company, has announced the final closing of Biofund IV at €215m (US$252m), some 35% larger than its previous […]
Kurma Partners, a European healthcare venture capital firm and a Eurazeo group company, has announced the final closing of Biofund IV at €215m (US$252m), some 35% larger than its previous […]
France: Kurma Partners closes Biofund IV at €215m
April 23, 2026
Healthcare
Life Sciences
News
Pharma
Venture
Germany: Innodiab expands Certania’s Life Sciences capabilities in diabetes and obesity
InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands our Life Sciences clinical research […]
InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands our Life Sciences clinical research […]
Germany: Innodiab expands Certania’s Life Sciences capabilities in diabetes and obesity
April 23, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
UK: Bay Tree completes investment in Medicare Insourcing Services
Bay Tree Private Equity, a UK-based private equity firm investing in lower mid-market businesses, has completed an investment in Medicare Insourcing Services, a provider of clinical insourcing services to the […]
Bay Tree Private Equity, a UK-based private equity firm investing in lower mid-market businesses, has completed an investment in Medicare Insourcing Services, a provider of clinical insourcing services to the […]
UK: Bay Tree completes investment in Medicare Insourcing Services
April 23, 2026
Debt
Diagnostics
Healthcare
M&A
News
From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences […]
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences […]
From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium
April 22, 2026
Analysis
Life Sciences
News
Aymen Mahmoud
Emmanuelle Trombe
France: Praemia REIM appoints Lionel Paquin as CEO
Praemia REIM, a key European real estate asset management player with an asset portfolio over half of which is in the healthcare/education sector, has appointed Lionel Paquin as Group CEO as part of […]
Praemia REIM, a key European real estate asset management player with an asset portfolio over half of which is in the healthcare/education sector, has appointed Lionel Paquin as Group CEO as part of […]
France: Praemia REIM appoints Lionel Paquin as CEO
April 22, 2026
Care Homes
Education
Healthcare
News
People
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m
Nasdaq-listed QuidelOrtho Corporation, a global leader of innovative in vitro diagnostics, has completed the acquisition of LEX Diagnostics for approximately US$100m. LEX Diagnostics is a UK-based molecular diagnostics company and a spin-out […]
Nasdaq-listed QuidelOrtho Corporation, a global leader of innovative in vitro diagnostics, has completed the acquisition of LEX Diagnostics for approximately US$100m. LEX Diagnostics is a UK-based molecular diagnostics company and a spin-out […]
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m
April 21, 2026
Diagnostics
Healthcare
Life Sciences
M&A
Medtech – Hospital Equipment
UK: AMS confirms discussions with TA Associates regarding a possible takeover
Listed Advanced Medical Solutions (AMS) has confirmed it is in discussions with TA Associates, a US private equity firm investment team specialising in five target industries: technology, financial services, healthcare, […]
Listed Advanced Medical Solutions (AMS) has confirmed it is in discussions with TA Associates, a US private equity firm investment team specialising in five target industries: technology, financial services, healthcare, […]
UK: AMS confirms discussions with TA Associates regarding a possible takeover
April 20, 2026
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Public Equity
Financing the future of elderly care in Germany: Carestone CEO Daniel Ahrendt talks market dynamics and growth
Germany-based real estate platform Carestone specialises in the development, construction and sale of senior living and care home assets. Headquartered in Hanover, it has become one of the leading developers […]
Germany-based real estate platform Carestone specialises in the development, construction and sale of senior living and care home assets. Headquartered in Hanover, it has become one of the leading developers […]
Financing the future of elderly care in Germany: Carestone CEO Daniel Ahrendt talks market dynamics and growth
April 20, 2026
Analysis
Care Homes
News
Real Assets
Social Care
Finland: Northern Horizon expands in Finland through three forward-funding deals
Northern Horizon, a specialised social infrastructure asset manager in the Nordics, has completed three forward funding deals acquisitions in Finland for approximately €28m. The new assets – in Jyväskylä, Pori and Kuopio […]
Northern Horizon, a specialised social infrastructure asset manager in the Nordics, has completed three forward funding deals acquisitions in Finland for approximately €28m. The new assets – in Jyväskylä, Pori and Kuopio […]
Finland: Northern Horizon expands in Finland through three forward-funding deals
April 20, 2026
Care Homes
News
Real Assets
Social Care
Finland
Hungary: Affidea exits Hungary with operations transferring to Medicare Group
Affidea, a Netherlands-based leading pan-European provider of community-based polyclinics, specialised services and advanced diagnostics, has transferred its operations in Hungary to local healthcare provider Medicare Group. Formed in Hungary in 1998, […]
Affidea, a Netherlands-based leading pan-European provider of community-based polyclinics, specialised services and advanced diagnostics, has transferred its operations in Hungary to local healthcare provider Medicare Group. Formed in Hungary in 1998, […]
Hungary: Affidea exits Hungary with operations transferring to Medicare Group
April 20, 2026
Diagnostics
Healthcare
M&A
News
Affidea
Netherlands: EQT Life Sciences takes €25m of Onward’s €40m private placement
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, has €40.6m by way of an accelerated bookbuild offering through […]
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, has €40.6m by way of an accelerated bookbuild offering through […]
Netherlands: EQT Life Sciences takes €25m of Onward’s €40m private placement
April 17, 2026
Life Sciences
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
News
Public Equity
Lithuania: Sectra strengthens position as provider of advanced, regulatory-approved AI solutions for diagnostic imaging with acquisition of Oxipit
Sweden-based international medical imaging IT and cybersecurity company Sectra has completed the acquisition of Lithuania-based Oxipit, a pioneer in autonomous AI for radiology and the developer of the first solution with […]
Sweden-based international medical imaging IT and cybersecurity company Sectra has completed the acquisition of Lithuania-based Oxipit, a pioneer in autonomous AI for radiology and the developer of the first solution with […]
Lithuania: Sectra strengthens position as provider of advanced, regulatory-approved AI solutions for diagnostic imaging with acquisition of Oxipit
April 17, 2026
Diagnostics
Healthcare
Life Sciences
M&A
Medtech – Diagnostics
India: Everstone Capital invests close to US$270m for a substantial stake in the Apothecon Group
Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a substantial stake in the Apothecon Group. […]
Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a substantial stake in the Apothecon Group. […]
India: Everstone Capital invests close to US$270m for a substantial stake in the Apothecon Group
April 17, 2026
Manufacturing – Generics
News
Pharma
Venture
Apothecon
UK: Charterhouse reaches agreement on recommended acquisition of Animalcare
Charterhouse Capital Partners has reached an agreement to acquire all shares of York-based AIM-listed international veterinary sales and marketing organisation, Animalcare, for approximately £235.2m on a fully diluted basis. Under the […]
Charterhouse Capital Partners has reached an agreement to acquire all shares of York-based AIM-listed international veterinary sales and marketing organisation, Animalcare, for approximately £235.2m on a fully diluted basis. Under the […]
UK: Charterhouse reaches agreement on recommended acquisition of Animalcare
April 16, 2026
Animal Health
M&A
News
Public Equity
Veterinary
UK: British Business Bank agrees £100m cornerstone commitment to Apposite Healthcare Growth I
The British Business Bank, the UK government’s economic development bank, has agreed to make a £100m (US$135.5m) commitment to Apposite Healthcare Growth I, a fund investing to support the growth […]
The British Business Bank, the UK government’s economic development bank, has agreed to make a £100m (US$135.5m) commitment to Apposite Healthcare Growth I, a fund investing to support the growth […]
UK: British Business Bank agrees £100m cornerstone commitment to Apposite Healthcare Growth I
April 16, 2026
Diagnostics
Digital Health/Healthtech
Healthcare
Life Sciences
News
Spain: Cofinimmo to build 150-bed care home in Spain
Cofinimmo, the Belgium-based REIT merging with Aedifica, is build a new nursing and care home in Seville, Spain. The investment budget for both the plot of land and the works […]
Cofinimmo, the Belgium-based REIT merging with Aedifica, is build a new nursing and care home in Seville, Spain. The investment budget for both the plot of land and the works […]
Spain: Cofinimmo to build 150-bed care home in Spain
April 16, 2026
Care Homes
News
Real Assets
Social Care
Cofinimmo
The latest insights from
Compass Carter Osborne
Insights from the Investors in Healthcare Real Assets Conference
Insights from the Investors in Healthcare Real Assets Conference
February 9, 2026
Healthcare
Insight
Digital transformation or change fatigue? Navigating tech in health and care
Digital transformation or change fatigue? Navigating tech in health and care
November 24, 2025
Healthcare
Insight